Stories

World No Tobacco Day is renewing debate over whether global tobacco control should focus more on engagement with smokers rather than exclusion or stigma. Harm reduction advocates argue that people who smoke are more likely to benefit from accurate information, practical support and access to lower-risk alternatives than from shame-based messaging. The discussion highlights concerns that abstinence-only approaches may overlook the behavioural realities of nicotine dependence and the needs of smokers who have not quit through conventional methods. A more inclusive public health strategy would prioritise empathy, risk reduction and evidence-based pathways away from combustible tobacco.

The transition to a new nicotine era is raising complex questions for tobacco-growing communities, particularly in countries where farming livelihoods remain closely tied to combustible tobacco markets. Indian farmers face structural barriers to diversification, including limited access to alternative crops, market uncertainty, debt pressures and dependence on established tobacco supply chains. The debate highlights that tobacco harm reduction and tobacco control policy cannot focus only on consumers, but must also consider the economic realities of producers. A sustainable shift away from smoking-related harm will require evidence-based regulation, viable agricultural transition pathways and policies that support farmers rather than leaving them behind.

Risk analysis of nicotine and tobacco products requires a clear distinction between combustible smoke exposure and non-combustible forms of nicotine delivery. Evidence on cancer and non-cancer risks continues to show that the greatest health burden is linked to toxicants produced through combustion, rather than nicotine itself. Researchers argue that comparing products through relative risk, exposure levels and disease pathways is essential for avoiding misleading conclusions in public health communication. The analysis reinforces the importance of evidence-based regulation that recognises meaningful differences between cigarettes, vaping products and other smoke-free nicotine alternatives.

Australia’s smoking cessation strategy is facing renewed scrutiny as experts call for a more pragmatic approach to helping smokers quit. Critics argue that current policy has become too restrictive, particularly around vaping, while combustible cigarettes and illicit tobacco remain widely available. The debate highlights growing concern that limiting access to lower-risk nicotine alternatives may undermine cessation efforts for people who have not succeeded with conventional methods. Questions remain over whether Australia’s public health framework can better balance prevention, medical support, harm reduction and real-world smoker behaviour.

The European Conference on Tobacco or Health 2026 in Milan aimed at advocating for strict regulations and measures to control tobacco and nicotine products. The declaration suggested making cities nicotine-free, enforcing uniform regulations on all products, and enhancing price policies. The text also emphasized protection of non-smokers, integrating control measures into urban policies, and investing in cessation services. However, critics argue that the declaration overlooks harm reduction strategies, obstructs access to safer products for smokers, and lacks consideration for individual choices. The conference's focus on enforcement, industry interference, and disregarding harm reduction leads to skepticism about its real impact on public health.

Russia’s proposed compromise on vaping regulation is facing early challenges as policymakers continue to weigh regional restrictions against broader market controls. Business groups and harm reduction advocates warn that fragmented bans could weaken legal trade, encourage illicit supply and reduce access to lower-risk alternatives for adult smokers. The debate highlights ongoing tensions between youth prevention, enforcement capacity, taxation interests and evidence-based approaches to nicotine regulation. Questions remain over whether a regional pilot model can produce meaningful public health benefits without repeating the unintended consequences seen in more prohibition-focused markets.

Calls for stricter vape bans in Scotland are adding to wider debate over how governments should regulate reduced-risk nicotine products. Critics argue that broad restrictions may undermine harm reduction by making it harder for adult smokers to access alternatives to combustible tobacco. The debate also raises questions about whether policies focused on visibility, flavours and public use can balance youth protection with the needs of smokers trying to quit. Concerns remain that treating vaping primarily as a public nuisance rather than a smoking cessation and harm reduction tool may weaken progress towards reducing smoking-related disease.

Canada’s latest youth vaping data are adding to debate over how reduced-risk nicotine products should be regulated within smoke-free strategies. Reports of historically low youth vaping rates challenge claims that adult access to vaping inevitably drives widespread youth uptake. Harm reduction advocates argue that regulated vaping products can support declines in smoking by offering adult smokers a less harmful alternative to combustible tobacco. The debate highlights the need for nicotine policy that protects young people while preserving proportionate access to lower-risk options for adults trying to quit smoking.

Sweden criticizes France's ban on nicotine pouches, fearing criminal penalties for Swedes carrying legal products. The dispute reveals differing European views on nicotine with accusations of Paris going too far. While France justifies the ban for public health reasons, Sweden views it as an attack on their lifestyle. The ban highlights a contradiction in tobacco control as countries restrict smoke-free products while cigarettes remain widely available. The EU is reviewing tobacco regulations, as individual states take varied approaches. France's ban faces legal challenges, focusing on commercial supply. The dispute reflects a wider debate on harm reduction and European nicotine policies.

UK nicotine pouch users travelling to France are being warned to check local rules carefully as the country moves towards strict restrictions on non-medicinal oral nicotine products. Proposed measures would cover not only the sale and importation of nicotine pouches, but also personal possession and use, creating potential legal risks for travellers carrying products bought legally elsewhere. Critics argue that such policies may criminalise consumers while reducing access to lower-risk alternatives for adults who no longer smoke or are trying to avoid cigarettes. The warning reflects wider concerns about the growing inconsistency of nicotine regulation across Europe and the unintended consequences of prohibition-led approaches.